scholarly journals In Vitro Effect of Dexamethasone, Pentoxifylline, and Anti-Endotoxin Monoclonal Antibody on the Release of Proinflammatory Mediators by Human Leukocytes Stimulated with Haemophilus influenzae Type B

1994 ◽  
Vol 35 (6) ◽  
pp. 725-728 ◽  
Author(s):  
A Marceline Van Furth ◽  
Thea M Steenwijk ◽  
Jan A M Langermans ◽  
Ralph Van Furth
Keyword(s):  
Monoclonal Antibody ◽  
Haemophilus Influenzae ◽  
Haemophilus Influenzae Type ◽  
Haemophilus Influenzae Type B ◽  
Type B ◽  
Human Leukocytes ◽  
Proinflammatory Mediators ◽  
Vitro Effect

In Vitro Activation of Human T Lymphocytes by Haemophilus influenzae Type b Capsular Polysaccharides

1992 ◽  
Vol 35 (2) ◽  
pp. 137-148 ◽  
Author(s):  
C. C. A. M. PEETERS ◽  
A.-M. TENBERGEN-MEEKES ◽  
C. J. HEIJNEN ◽  
J. T. POOLMAN ◽  
B. J. M. ZEGERS ◽  
...  
Keyword(s):  
T Lymphocytes ◽  
Haemophilus Influenzae ◽  
Haemophilus Influenzae Type ◽  
Haemophilus Influenzae Type B ◽  
Capsular Polysaccharides ◽  
Type B ◽  
Human T Lymphocytes ◽  
In Vitro Activation

Letters to the Editor

PEDIATRICS ◽  
1980 ◽  
Vol 66 (1) ◽  
pp. 154-155
Author(s):  
Charles M. Ginsburg ◽  
John D. Nelson
Keyword(s):  
Staphylococcus Aureus ◽  
Haemophilus Influenzae ◽  
Bacterial Pneumonia ◽  
Hospitalized Patients ◽  
Haemophilus Influenzae Type ◽  
Haemophilus Influenzae Type B ◽  
Type B ◽  
Letters To The Editor ◽  
And Staphylococcus Aureus

We do not disagree with the recommendations of Drs Fischer, Bass, and Arthur for treating hospitalized patients with pneumonia. They might have mentioned, additionally, the possible utility of cefamandole as an alternative to a penicillinase-resistant penicillin plus chloramphenicol for hospitalized infants with presumed bacterial pneumonia. We are currently evaluating cefuroxime, which has a similar in vitro spectrum, and are finding it effective in patients with pneumonia due to Haemophilus influenzae type b, pneumococci and Staphylococcus aureus.

Specific detection of Haemophilus influenzae type b lipooligosaccharide by a polymyxin B monoclonal antibody assay

1989 ◽  
Vol 122 (2) ◽  
pp. 219-226 ◽  
Author(s):  
Jussi Mertsola ◽  
Octavio Ramilo ◽  
Xavier Sáez-Llorens ◽  
Mark S. Hanson ◽  
George H. McCracken ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Haemophilus Influenzae ◽  
Polymyxin B ◽  
Haemophilus Influenzae Type ◽  
Haemophilus Influenzae Type B ◽  
Type B ◽  
Specific Detection ◽  
Antibody Assay

scholarly journals Identification of Haemophilus influenzae type b by a monoclonal antibody coagglutination assay.

1987 ◽  
Vol 25 (12) ◽  
pp. 2434-2436 ◽  
Author(s):  
J Hamel ◽  
B R Brodeur ◽  
A Belmaaza ◽  
S Montplaisir ◽  
J M Musser ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Haemophilus Influenzae ◽  
Haemophilus Influenzae Type ◽  
Haemophilus Influenzae Type B ◽  
Type B

In Vivo and In Vitro Expression of Haemophilus influenzae Type b Lipooligosaccharide Epitopes

1991 ◽  
Vol 164 (3) ◽  
pp. 555-563 ◽  
Author(s):  
J. Mertsola ◽  
L. D. Cope ◽  
X. Saez-Llorens ◽  
O. Ramilo ◽  
W. Kennedy ◽  
...  
Keyword(s):  
Haemophilus Influenzae ◽  
Haemophilus Influenzae Type ◽  
Haemophilus Influenzae Type B ◽  
Type B ◽  
In Vitro Expression

Safety and Immunogenicity of Haemophilus influenzae Type b Oligosaccharide-CRM197 Conjugate Vaccine in Infants Aged 15 to 23 Months

PEDIATRICS ◽  
1990 ◽  
Vol 86 (4) ◽  
pp. 527-534
Author(s):  
Dace Viceps Madore ◽  
Cynthia L. Johnson ◽  
Donna C. Phipps ◽  
Martin G. Myers ◽  
Ronald Eby ◽  
...  
Keyword(s):  
Haemophilus Influenzae ◽  
Capsular Polysaccharide ◽  
Geometric Mean ◽  
Haemophilus Influenzae Type ◽  
Antibody Concentration ◽  
Haemophilus Influenzae Type B ◽  
Type B ◽  
Polysaccharide Antibody ◽  
Covalently Linked

A total of 268 infants aged 15 to 23 months received one dose of a vaccine composed of Haemophilus influenzae type b oligosaccharides covalently linked to the nontoxic diphtheria toxin variant CRM197 (HbOC; HibTITER). Side effects associated with vaccination were infrequent, transient, and mild. One month after a single vaccination, the anti-H influenzae type b capsular polysaccharide antibody concentration rose from a geometric mean prevaccination level of 0.20 µg/mL to 13.77 µg/mL. Of these infants, 99% had a postvaccination level greater than or equal to 1.00 µg/mL, a level associated with long-term protection. The immune response was long-lived: all of the children who were monitored 17 to 27 months after vaccination had concentrations greater than or equal to 1.00 µg/mL. The anti-H influenzae type b capsular polysaccharide antibody generated was predominantly of the IgG isotype and IgG1 subclass. The immune sera had bactericidal activity in vitro and conferred passive protection in the infant rat meningitis model.

Sign in / Sign up

Export Citation Format

Share Document